A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z

Clinical trial NCT06929260 · TERMINATED

Trial details

NCT number: NCT06929260
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumours

Start date: 2025-05-21
Primary completion: 2025-10-15
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.